Cationic lipid-mediated transfer of the hIL-10 gene prolongs survival of allogeneic hepatocytes in Nagase analbuminemic rats.

Gene transfer techniques can be used as a drug delivery system to achieve local immunosuppression. We performed a series of experiments to identify the cationic lipid that most efficiently transfects isolated, cultured, rat hepatocytes; to optimize conditions for efficient transfection; to determine the duration of gene expression in vitro; and finally, to determine the survival of allogeneic hepatocytes transplanted into Nagase rats. Our results suggest that DOTAP is the best cationic lipid for transfection of cultured rat hepatocytes. In addition, the following conditions appear to optimize transfection efficiency: a DNA:DOTAP ratio of 1:6; a 24 exposure time of the hepatocytes to the DNA-DOTAP complex; a DNA dose of 4 microg/35 mm culture plate seeded with 2.5x10(5) rat hepatocytes. When transfected as described above, cultured hepatocytes expressed the hIL-10 gene for approximately 14 days. Accordingly, Nagase rats transplanted with 4x10(7) DOTAP-hIL-10 transfected, allogeneic hepatocytes had an abrupt rise in serum albumin levels that peaked within 7 days of the transplant, decreased abruptly after 15 days, and approached baseline by day 40. In contrast, control animals had a smaller albumin peak that returned to baseline within 10 days (P<0.01). In all animals, serum hIL-10 levels were undetectable when tested. We conclude that DOTAP is the best cationic lipid for transfection of cultured rat hepatocytes. Furthermore, hIL-10 transfected hepatocytes have a prolonged survival in an allogeneic host which is probably limited by loss of gene expression. Further studies using other vectors capable of prolonged gene expression will help determine if indefinite hIL-10 gene expression leads to indefinite graft survival.

[1]  J. Wilson,et al.  Adenoviruses as gene-delivery vehicles. , 1996, The New England journal of medicine.

[2]  J. Bromberg,et al.  IL-10 immunosuppression in transplantation. , 1995, Current opinion in immunology.

[3]  E. Marshall Gene therapy's growing pains , 1995, Science.

[4]  Joseph Zabner,et al.  Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid (*) , 1995, The Journal of Biological Chemistry.

[5]  M. Lotze,et al.  Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors , 1995, The Journal of experimental medicine.

[6]  A. Fabrega,et al.  Amelioration of analbuminemia by transplantation of allogeneic hepatocytes in tolerized rats. , 1995, Transplantation.

[7]  P. Nickerson,et al.  Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. , 1995, Journal of immunology.

[8]  P. Linsley,et al.  CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 , 1995, The Journal of experimental medicine.

[9]  C. Stoeckert,et al.  IMMUNOMODULATION OF PANCREATIC ISLET ALLOGRAFTS IN MICE WITH CTLA4Ig SECRETING MUSCLE CELLS , 1995, Transplantation.

[10]  A. Shaked,et al.  Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10. , 1995, Transplantation.

[11]  S. Narula,et al.  Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice. , 1995, Transplantation proceedings.

[12]  S. Gruber Local immunosuppressive therapy in organ transplantation. , 1994, Transplantation proceedings.

[13]  J. Roy-Chowdhury,et al.  Human liver cell transplantation. Prolonged function in athymic-Gunn and athymic-analbuminemic hybrid rats. , 1989, Gastroenterology.

[14]  S. Nagase,et al.  Albumin-deficient rat mutant. , 1979, Science.

[15]  H. Stone Preoperative and postoperative care. , 1977, The Surgical clinics of North America.

[16]  D. Friend,et al.  HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS , 1969, Journal of Cell Biology.

[17]  R. de Waal Malefyt,et al.  Biological properties of interleukin 10. , 1992, Immunology today.